Exact Mass: 615.1143

Exact Mass Matches: 615.1143

Found 18 metabolites which its exact mass value is equals to given mass value 615.1143, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

CXCR3 Antagonist 6c

4-[2-(3-chlorobenzamido)-4-{[2-(2,4-dichlorophenyl)ethyl]carbamoyl}phenyl]-N-ethyl-1,4-diazepane-1-carboxamide

C30H32Cl3N5O3 (615.1571)


   

Idasanutlin

4-[[3-(3-Chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-(2,2-dimethylpropyl)pyrrolidine-2-carbonyl]amino]-3-methoxybenzoic acid

C31H29Cl2F2N3O4 (615.1503)


   

Trametinib

Trametinib (GSK1120212)

C26H23FIN5O4 (615.0779)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EE - Mitogen-activated protein kinase (mek) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C69145 - Mitogen-Activated Protein Kinase Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor D000970 - Antineoplastic Agents Trametinib (GSK1120212; JTP-74057) is an orally active MEK inhibitor that inhibits MEK1 and MEK2 with IC50s of about 2 nM. Trametinib activates autophagy and induces apoptosis[1][2].

   
   

convolutamide E|N-Octadecanoyl-Deacylconvolutamide

convolutamide E|N-Octadecanoyl-Deacylconvolutamide

C28H43Br2NO4 (615.1559)


   

Fmoc-tyr(2-br-z)-oh

Fmoc-tyr(2-br-z)-oh

C32H26BrNO7 (615.0893)


   
   

Idasanutlin

Idasanutlin

C31H29Cl2F2N3O4 (615.1503)


C274 - Antineoplastic Agent > C129839 - Apoptotic Pathway-targeting Antineoplastic Agent > C162996 - MDM2 Inhibitor Idasanutlin (RG7388) is a potent and selective MDM2 antagonist, inhibiting p53-MDM2 binding, with an IC50 of 6 nM.

   

N-(3-(3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-diMethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyriMidin-5-ylaMino)phenyl)acetaMide

N-(3-(3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-diMethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyriMidin-5-ylaMino)phenyl)acetaMide

C26H23FIN5O4 (615.0779)


   

Dabrafenib Mesylate

Dabrafenib Mesylate

C24H24F3N5O5S3 (615.0892)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2336 - Raf Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor Dabrafenib Mesylate is a potent and selective Raf kinase inhibitor with IC50s of 0.6 and 5.0 nM for RafV600E and c-Raf, respectively.

   

4-Chloro-N-{[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetyl}-N-(4-methoxyphenyl)benzohydrazide

4-Chloro-N-{[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetyl}-N-(4-methoxyphenyl)benzohydrazide

C33H27Cl2N3O5 (615.1328)


   

Lamellarin alpha 20-sulfate

Lamellarin alpha 20-sulfate

C29H22NNaO11S (615.0811)


An organic sodium salt of lamellarin alpha 20-hydrogen sulfate. It is isolated from an unidentified ascidian (IIC-197) and exhibits inhibitory activity against HIV-1 integrase.

   

N-[3-(4-{[1-(5-chloro-2,4-dimethoxyanilino)-1-oxopropan-2-yl]sulfanyl}anilino)-3-oxo-1-phenylprop-1-en-2-yl]benzamide

N-[3-(4-{[1-(5-chloro-2,4-dimethoxyanilino)-1-oxopropan-2-yl]sulfanyl}anilino)-3-oxo-1-phenylprop-1-en-2-yl]benzamide

C33H30ClN3O5S (615.1595)


   

1,N-bis(2,4-dinitrophenyl)-L-histidyl-L-glutamine

1,N-bis(2,4-dinitrophenyl)-L-histidyl-L-glutamine

C23H21N9O12 (615.131)


   

[(2R,3S,4R)-2-[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxymethyl]-4,5-dihydroxyoxolan-3-yl] propanoate

[(2R,3S,4R)-2-[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxymethyl]-4,5-dihydroxyoxolan-3-yl] propanoate

C18H27N5O15P2 (615.0979)


   

3-(3,4-dibromo-5-hydroxyphenyl)-3-hydroxy-1-octadecanoylpyrrolidin-2-one

3-(3,4-dibromo-5-hydroxyphenyl)-3-hydroxy-1-octadecanoylpyrrolidin-2-one

C28H43Br2NO4 (615.1559)


   

(7s,8s,12r,13s)-22-chloro-1,3,8,28-tetrahydroxy-7,12,21-trimethoxy-6-methyl-14,16,19-trioxa-6-azaheptacyclo[15.11.1.0²,¹¹.0⁴,⁹.0¹³,²⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-2,4(9),10,17(29),18(27),20,22,24-octaene-5,26-dione

(7s,8s,12r,13s)-22-chloro-1,3,8,28-tetrahydroxy-7,12,21-trimethoxy-6-methyl-14,16,19-trioxa-6-azaheptacyclo[15.11.1.0²,¹¹.0⁴,⁹.0¹³,²⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-2,4(9),10,17(29),18(27),20,22,24-octaene-5,26-dione

C29H26ClNO12 (615.1143)


   

(3s)-3-(3,4-dibromo-5-hydroxyphenyl)-3-hydroxy-1-octadecanoylpyrrolidin-2-one

(3s)-3-(3,4-dibromo-5-hydroxyphenyl)-3-hydroxy-1-octadecanoylpyrrolidin-2-one

C28H43Br2NO4 (615.1559)